The Correlation of Plasma Malondialdehyde Level Elevation with Infarct Volume on Brain MSCT and BI among patients with Acute Ischemic Stroke

Retnaningsih Retnaningsih

Abstract


Stroke is neurovascular impairment, contributing to the forth common cause of death in the world. Furthermore, stroke is the most common cause of disability. Acute ischemic stroke (AIS) were defined as broaden infarct after 48-72 hours of onset. Oxidative stress plays an important role in brain damage after stroke. During oxidative stress, free radicals were released by lipid peroxidation with malondialdehyde (MDA) as the marker. The objective of this research is to analyze the correlation of plasma malondialdehyde level elevation with infarct volume on brain MSCT and BI among patients with acute ischemic stroke. This is an observational study with cross sectional design conducted in Stroke Unit, Dr. Kariadi General Hospital Semarang. Fourty-three patients with AIS within ≤ 72 hours of onset were include in this study. The diagnosis and the infarct volume were confirmed by MSCT. MDA level was measured by using TBARS method. The clinical neurology was assesed by Bartel Index (BI). The statistical and correlation analysis were performed by Spearman’s Rho test. There is no significant differences in plasma MDA level elevation with infarct volume size. There is significant correlation between infarct volume and BI at admission. There is no significant correlation between plasma MDA level elevation and infarct volume also BI admission. There is no significant correlation between plasma MDA level elevation and infarct volume size. There is significant correlation between infarct volume size and BI admission.

Keywords


Plasma MDA level, Acute ischemic stroke, Infarct volume, Brain MSCT

Full Text:

PDF

References


Kim AS, Johnston SC, “Global variation in the relative burden of stroke and ischemic heart disease”, Circulation, 2011, 124(3):314-23.

Danton GH, Dietrich WD, “The search for neuroprotective strategies in stroke”, American journal of neuroradiology, 2004, 25(2):181-94.

Kaur J, Arora S, Singh B, Thakur L, Gambhir J, Prabhu K, “Role of oxidative stress in pathophysiology of transient ischemic attack and stroke”, 2011.

Chen S-D, Yang D-I, Lin T-K, Shaw F-Z, Liou C-W, Chuang Y-C, “Roles of Oxidative Stress, Apoptosis, PGC-1 and Mitochondrial Biogenesis in Cerebral Ischemia”, Int. J. Mol. Sci. 2011, 12:7199-215.

Dharap A, Nakka VP, Vemuganti R, “Effect of focal ischemia on long noncoding RNAs”, Stroke, 2012, 43(10):2800-2.

Bir LSL, Demir SS, Rota SS, Köseoğlu MM, “Increased serum malondialdehyde level in chronic stage of ischemic stroke”, Tohoku J. Exp. Med. 208, 2008, 1:33-9.

Rodrigo R, Fernandez-Gajardo R, Gutierrez R, Manuel Matamala J, Carrasco R, Miranda-Merchak A, “Oxidative stress and pathophysiology of ischemic stroke: novel therapeutic opportunities”, CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS & Neurological Disorders), 2013, 12(5):698-714.

Madamanchi NR, Vendrov A, Runge MS, “Oxidative stress and vascular disease”, Arterioscler Thromb. Vasc. Biol. 2005, 25(1):29-38.

Manzanero S, Santro T, Arumugam TV, “Neuronal oxidative stress in acute ischemic stroke: Sources and contribution to cell injury”, Neurochemistry international, 2012.

Kato Y, Osawa T, “Detection of lipid-lysine amide-type adduct as a marker of PUFA oxidation and its applications”, Archives of biochemistry and biophysics, 2010, 501(2):182-7.

Kimura Y, Sato M, Kurotani K, Nanri A, Kawai K, Kasai H, “ PUFAs in serum cholesterol ester and oxidative DNA damage in Japanese men and women”, The American journal of clinical nutrition, 2012, 95(5):1209-14.

Marsh B, “Systemic lipopolysaccharide protects the brain from ischemic injury by reprogramming the response of the brain to stroke: a critical role for IRF3”, J. Neurosci. [10.1523/JNEUROSCI.2496-09.2009], 2009, 29:9839-49.

Kumar A, Mittal R, Khanna HD, Sriparna Basu, “Free Radical Injury and Blood-Brain Barrier Permeability in Hypoxic-Ischemic Encephalopathy”, Pediatrics, 2008, 122;e722. 2008;122:e722.

Grotto D, Maria LS, Valentini J, Paniz C, Garcia GSeSC, Pomblum VJ, “Importance of the lipid peroxidation biomarkers and methodological aspects FOR malondialdehyde quantification”, Quim Nova, 2009, 32(1):169-74.

Giffard RG, Xu L, Zhao H, Carrico W, Ouyang Y, Sapolsky R, “Chaperones, protein aggregation, and brain protection from hypoxic/ischemic injury”, The Journal of Experimental Biology 207, 2004, 207:3213-20.

Kaur J, Arora S, Singh B, Thakur L, Gambhir J, Prabhu K, “Role of Oxidative Stress in Pathophysiology of Transient Ischemic Attack and Stroke”, Int. J. Biol. Med. Res., 2011, 2(3):611-5.

Domínguez C, Delgado P, Vilches A, Martín-Gallán P, Marc Ribó E, Santamarina, “Oxidative Stress After Thrombolysis-Induced Reperfusion in Human Stroke”, Stroke, 2010, 41:653-60.

Adibhatla RM, Hatchera JF, “Phospholipase A2, reactive oxygen species, and lipid peroxidation in cerebral ischemia”, Free Radic. Biol. Med., 2006, 40(3):376-87.

Deb P, Sharma S, Hassan K, “Pathophysiologic mechanisms of acute ischemic stroke: an overview with emphasis on therapeutic significance beyond thrombolysis”, Pathophysiology, 2010, 17(3):197-218.

Huang M, Qian Y, Guan T, Huang L, Tang X, Li Y, “Different neuroprotective responses of Ginkgolide B and bilobalide, the two Ginkgo components, in ischemic rats with hyperglycemia, “European journal of pharmacology, 2012, 677(1):71-6.

Van der Worp, H. B., et al. "Reproducibility of measurements of cerebral infarct volume on CT scans." Stroke 32.2 (2001): 424-430.

Beg M, Gandhi S, Tamana Z, Akhtar N. “Serum Malondialdehyde level and lesion size in acute stroke”, Biomedical Research, 2005, 16(3):177-81.

Van Hartingsveld F, Lucas C, Kwakkel G, Lindeboom R, “Improved interpretation of stroke trial results using empirical Barthel item weights”, Stroke, 2006, 37(1):162-6.

Feigin VL, Lawes CM, Bennett DA, Anderson CS, “Stroke epidemiology: a review of population-based studies of incidence, prevalence, and case-fatality in the late 20th century”, The Lancet Neurology, 2003, 2(1):43-53.


Refbacks

  • There are currently no refbacks.


Bookmark and Share


Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.